Biodedegradable drug eluting stents market projected to generate significant sales for the market players over the forecast period

15/mag/2018 06:52:20 sravan Contatta l'autore

Questo comunicato è stato pubblicato più di 3 mesi fa. Le informazioni su questa pagina potrebbero non essere attendibili.

Biodedegradable drug eluting stents market projected to generate significant sales for the market players over the forecast period

 

Biodedegradable drug eluting stents market:

Drug-eluting stents are peripheral or coronary stents placed into narrowed peripheral or coronary arteries that slowly release the drug to block cell proliferation. Generally, these devices are made up of metal and remain permanently or removed with the help of another surgery. Metal stents present drawbacks such as the predisposition to late stent thrombosis, impairment of imaging with multislice CT, hindrance of surgical revascularization. Biodegradable drug-eluting stents are made up of material that dissolves or absorbed in the body, these are temporary, and no need for further surgery to removal of the stent. These are also called as bioresorbable stents or naturally- dissolving stents.

 

Global Biodegradable Drug Eluting Stents Market growth is driven by growing prevalence of coronary artery diseases, increased geriatric population who are more prone to heart diseases. According to World Health Organization (WHO),  cardiovascular diseases are a primary cause of deaths globally, representing 31% of all global deaths. Of these deaths, an estimated 7.4million were due to coronary heart disease and 6.7 million were due to heart stroke. Furthermore, biodegradable drug-eluting stents have various advantages over the traditional metal stents such as no need of further surgery to remove stent, quick restoration of blood flow and faster healing process which are expected to boost the biodegradable drug eluting stents market. However, a risk of complications in use and lower awareness about biodegradable stents among healthcare professionals in developing and developed regions are expected to hamper the growth of Biodegradable Drug Eluting Stents Market.

 

Free sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-biodegradable-drug-eluting-stents-market/#ulp-4H8Z4LpNMLEuOnnx

 

Biodegradable Drug Eluting Stents Market has been categorized into-

1.      Type of material

·         Metallic Alloy Stents

·         Polymeric Stents

2.     Applications

·         Coronary Artery Disease

·         Peripheral Artery Disease

 

3.      End-users

Hospitals and cardiac centers.

 

To view TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-biodegradable-drug-eluting-stents-market/#ulp-c654SbFYO64MsOhu

 

And lastly, on the basis of geographical regions it is divided into 5 major parts-i.e. North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. In North America, U.S. represents the largest market owing to the higher prevalence of cardiovascular diseases especially coronary artery diseases. Asia Pacific region is expected significant growth rate due to increasing awareness about biodegradable drug eluting stents. In Asia region, India, China, Japan are expected to grow at significant rate owing to rise in prevalence of chronic diseases, such as diabetes and cardiac diseases which are expected to boost the demand for biodegradable drug eluting stents. 

 

Some of the key players in global biodegradable drug eluting stents market include Biosensors International Group (Singapore), Abbott Laboratories (U.S), Medtronic (U.S.), B. Braun Holding GmbH & Co. KG (B.Braun Melsungen) (Germany), Boston Scientific Corporation (U.S.), and Terumo Corporation (Japan) to name a few. In 2015, Boston Scientific Corporation received USFDA approval for the synergy bioabsorbable Polymer Drug-Eluting Stent System (BP-DES) for the treatment of coronary artery disease.

 

Need more information about this report @

https://www.precisionbusinessinsights.com/market-reports/global-biodegradable-drug-eluting-stents-market/#ulp-14mlyhjMGhVjZqa3

 

 

Market players are focusing on product development with extensive R&D, mergers and acquisitions, partnerships, and collaborations. For example, in 2014, Terumo Medical Corporation partnered with Arterial Remodeling Technologies to develop bioresorbable stents with the help of Arterial Remodeling Technologies. Larger players, such as Abbott and Biosensors International, are developing innovative biodegradable stents to reduce the complications post-percutaneous coronary intervention procedures. The application segments coronary artery segment expected to account for major market share as eluting stents are considered as ideal for treating coronary artery disease.

 

Get access to full summary @

https://www.precisionbusinessinsights.com/market-reports/global-biodegradable-drug-eluting-stents-market/

 

About Precision Business Insights

Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

Contact to Precision Business Insights,

Kemp House,

152 – 160 City Road,

London EC1V 2NX

Email: sales@precisionbusinessinsights.com

Toll Free (US):+1-866-598-1553

Website @https://www.precisionbusinessinsights.com

 

blog comments powered by Disqus
Comunicati.net è un servizio offerto da Factotum Srl